Article Details
Retrieved on: 2021-04-10 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The checkpoint inhibitors used to treat NSCLC target the proteins PD-1 or PD-L1, which deter immune system T cells from attacking tumor cells.
Article found on: www.eurekalert.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here